Breaking News Instant updates and real-time market news.

HAS

Hasbro

$100.00

-20.11 (-16.74%)

08:34
10/23/19
10/23
08:34
10/23/19
08:34

Hasbro price target lowered to $90 from $105 at BMO Capital

BMO Capital analyst Gerrick Johnson lowered his price target on Hasbro to $90 and kept his Market Perform rating after its "sizable" sales and earnings miss in Q3, which the company attributed to the threat of tariffs disrupting its "ordering patterns". The analyst notes that investors were "surprised" that this "rock solid" company could not navigate around the trade impediments, but believes that the 17% decline in the stock price was also appropriate considering Hasbro's "stretched valuation".

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

HAS Hasbro
$100.00

-20.11 (-16.74%)

07/26/19
07/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) and Citi (C) upgraded to Outperform from Market Perform at Keefe Bruyette. 2. Ambev (ABEV) upgraded to Neutral from Underweight at JPMorgan with analyst Lucas Ferreira saying the post-earnings share rally shows that investors are chasing good growth stories to play Brazil's economic recovery. 3. West Pharmaceutical (WST) upgraded to Neutral from Underperform at BofA/Merrill with analyst Derik de Bruin saying that over the course of the first half, the company addressed his prior concerns around organic revenue growth and product mix trends while also boosting its operating margins and generating higher free cash flows. 4. Union Pacific (UNP) upgraded to Overweight from Neutral at Atlantic Equities, while CSX (CSX) was upgraded to Neutral from Underweight. 5. Hasbro (HAS) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's dominant position with a range of "strong" brands as well as in the big-screen business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/19
DADA
08/23/19
NO CHANGE
Target $138
DADA
Buy
Mattel could decline after Hasbro deal for Entertainment One, says DA Davidson
DA Davidson analyst Linda Bolton Weiser said Mattel (MAT) shares could decline as "it's now clear there will not be a HAS/MAT deal" following Hasbro's (HAS) agreement to acquire Entertainment One for $4B in cash. For Hasbro, she estimates the deal is at least 22c accretive to her 2020 EPS estimate, adding that eOne will give the company strong preschool properties and will let it unlock franchise economics across platforms. Weiser has a Buy rating and $138 price target on Hasbro shares.
09/10/19
JEFF
09/10/19
NO CHANGE
Target $130
JEFF
Buy
Hasbro shares can rally over 40% within two years, says Jefferies
Two "powerful, higher-margin engines" can drive shares of Hasbro higher by 40%-plus over the next one-to-two years, Jefferies analyst Stephanie Wissink tells investors in a research note. The analyst sees digital gaming and eOne media platform integration driving Hasbro's earnings growth higher. Further, modest core toy sales growth should generate cash flow to support investment, debt deleveraging, and the dividend, says Wissink. She reiterates Hasbro as a "Franchise Pick" with a Buy rating and $130 price target.
10/22/19
JEFF
10/22/19
NO CHANGE
Target $135
JEFF
Buy
Jefferies says Hasbro selloff as an 'overshoot,' would be buyers
Jefferies analyst Stephanie Wissink maintained a Buy rating and $135 price target on Hasbro following the company's Q3 results and the selloff that followed those results. The analyst noted that consumer demand is solid, and expects a "partial rebound in Q4," noting that U.S. inventory issues handicapped the Q3 results, and saying that those issues were "transitory and not systematic."

TODAY'S FREE FLY STORIES

BHVN

Biohaven Pharmaceutical

$53.89

1.41 (2.69%)

07:23
11/22/19
11/22
07:23
11/22/19
07:23
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$56.84

0.455 (0.81%)

07:23
11/22/19
11/22
07:23
11/22/19
07:23
Initiation
Bristol-Myers initiated  »

Bristol-Myers resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENR

Energizer

$49.05

1.33 (2.79%)

07:22
11/22/19
11/22
07:22
11/22/19
07:22
Recommendations
Energizer analyst commentary  »

Energizer Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,734.99

-10.51 (-0.60%)

, MSFT

Microsoft

$149.46

-0.14 (-0.09%)

07:20
11/22/19
11/22
07:20
11/22/19
07:20
Periodicals
Amazon suit to likely delay start of Pentagon technology program, Bloomberg says »

Amazon (AMZN) could…

AMZN

Amazon.com

$1,734.99

-10.51 (-0.60%)

MSFT

Microsoft

$149.46

-0.14 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

  • 09

    Dec

ABCB

Ameris Bancorp

$42.81

-0.4 (-0.93%)

07:19
11/22/19
11/22
07:19
11/22/19
07:19
Recommendations
Ameris Bancorp analyst commentary  »

Ameris Bancorp subpoena…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BWEN

Broadwind Energy

$1.44

-0.06 (-4.00%)

07:18
11/22/19
11/22
07:18
11/22/19
07:18
Hot Stocks
Broadwind Energy receives first solar market order »

Broadwind Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTC

Astrotech

$1.51

-0.06 (-3.83%)

07:18
11/22/19
11/22
07:18
11/22/19
07:18
Hot Stocks
Astrotech says 1st Detect sells TRACER 1000s to shipping & logistics company »

Astrotech Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGS

Medigus

$1.76

(0.00%)

07:17
11/22/19
11/22
07:17
11/22/19
07:17
Hot Stocks
Medigus receives $1.2M payment as part of MUSE agreement in China »

Medigus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:16
11/22/19
11/22
07:16
11/22/19
07:16
Hot Stocks
Breaking Hot Stocks news story on Destination XL »

Destination XL to close…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

T

AT&T

$37.59

0.415 (1.12%)

07:15
11/22/19
11/22
07:15
11/22/19
07:15
Recommendations
AT&T analyst commentary  »

AT&T near-term short…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:15
11/22/19
11/22
07:15
11/22/19
07:15
Hot Stocks
Destination XL expects FY19 free cash flow to be breakeven »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

ANIX

Anixa Biosciences

$3.50

-0.11 (-3.05%)

07:13
11/22/19
11/22
07:13
11/22/19
07:13
Hot Stocks
Anixa Biosciences announces Cchek study collaboration with UCA »

Anixa Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:13
11/22/19
11/22
07:13
11/22/19
07:13
Earnings
Destination XL reports Q3 adj. EPS (8c) vs. (2c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:11
11/22/19
11/22
07:11
11/22/19
07:11
Hot Stocks
Destination XL announces Ujjwal Dhoot as chief digital officer »

Destination XL announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

TREE

LendingTree

$365.30

-5.29 (-1.43%)

07:11
11/22/19
11/22
07:11
11/22/19
07:11
Initiation
LendingTree initiated  »

JPMorgan starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENR

Energizer

$49.05

1.33 (2.79%)

07:09
11/22/19
11/22
07:09
11/22/19
07:09
Hot Stocks
Energizer targets 'top-line growth above category' in FY20-FY22 »

Also targets adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$2.85

-0.05 (-1.72%)

07:08
11/22/19
11/22
07:08
11/22/19
07:08
Hot Stocks
Neovasc says Reducer featured during therapy development program in Coburg »

Neovasc announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$60.22

0.85 (1.43%)

07:08
11/22/19
11/22
07:08
11/22/19
07:08
Recommendations
ConocoPhillips analyst commentary  »

ConocoPhillips price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJM

J.M. Smucker

$104.40

-1.15 (-1.09%)

07:08
11/22/19
11/22
07:08
11/22/19
07:08
Hot Stocks
J.M. Smucker CEO says Q2 sales performance did not meet expectations »

"While our second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

LHCG

LHC Group

$131.10

0.57 (0.44%)

07:06
11/22/19
11/22
07:06
11/22/19
07:06
Hot Stocks
LHC Group, Texas Health, Methodist Health purchase Healthcare Resources »

LHC Group, Texas Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

SJM

J.M. Smucker

$104.40

-1.15 (-1.09%)

07:06
11/22/19
11/22
07:06
11/22/19
07:06
Earnings
J.M. Smucker cuts FY20 adj. EPS view to $8.10-$8.30 from $8.35-$8.55 »

Consensus $8.27. Cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

RMR

RMR Group

$48.26

0.02 (0.04%)

07:06
11/22/19
11/22
07:06
11/22/19
07:06
Earnings
RMR Group reports Q4 adj. EPS 59c, consensus 52c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

NAVB

Navidea

$0.71

-0.0322 (-4.34%)

07:05
11/22/19
11/22
07:05
11/22/19
07:05
Initiation
Navidea initiated  »

Navidea initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
11/22/19
11/22
07:05
11/22/19
07:05
General news
FX Update: The dollar has been trading steady-to-firmer »

FX Update: The dollar has…

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:04
11/22/19
11/22
07:04
11/22/19
07:04
Hot Stocks
Destination XL appoints Ujjwal Dhoot as CDO »

Destination XL Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.